Cargando…

Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets

Over the past few decades, drug discovery has greatly improved the outcomes for patients, but several challenges continue to hinder the rapid development of novel drugs. Addressing unmet clinical needs requires the pursuit of drug targets that have a higher likelihood to lead to the development of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Beis, G., Serafeim, A.P., Papasotiriou, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732000/
https://www.ncbi.nlm.nih.gov/pubmed/36514341
http://dx.doi.org/10.1016/j.csbj.2022.11.042

Ejemplares similares